Cardinal Health 414, LLC
Dublin, OH Nphs Part of Cardinal Health, Inc.
- UEI
- CWN9UGL3NCL9
- CAGE
- 3S229
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Cardinal Health, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Other
- Corporate family
-
-
Parent
QJNKEYPKMBA3
-
Parent
QJNKEYPKMBA3
- SAM.gov registration date
- Physical address
- 7000 Cardinal Pl, Dublin, OH 43017, USA
- Website
- cardinalhealth.com
- Founded
- 1971
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $545,669 |
| FY2026 | $24,107,564 |
| FY2025 | $30,362,934 |
| FY2024 | $21,205,607 |
| FY2023 | $29,669,542 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $20,318,244 | |
| 2 | Defense Health Agency | $3,852,331 | |
| 3 | Department of Health and Human Services | $477,423 | |
| 4 | Department of Justice | $5,235 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Lantheus Medical Imaging, Inc. | Bedford, MA | 325412 Pharmaceutical Preparation Manufacturing |
| GE Healthcare | Arlington Heights, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Sun Pharmaceutical Industries, Inc. | Princeton, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Heartlight Pharmacy Services | Lima, OH | 325412 Pharmaceutical Preparation Manufacturing |
| RLS (USA) Inc. | Lake Mary, FL | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Cardinal Health 414, LLC, Nphs Division, doing business as Cardinal Health 414, Inc., manufactures and distributes radiopharmaceuticals and medical isotopes to federal healthcare agencies as a prime contractor across full-and-open competition with no set-aside designations. A subsidiary of Dublin, Ohio-based Cardinal Health, Inc., Cardinal Health 414 holds single-award indefinite-delivery contracts and blanket purchase agreements exclusively with individual Veterans Integrated Service Networks and the Defense Health Agency, operating on firm fixed-price terms from its Dublin, Ohio facility.
Cardinal Health 414's federal footprint centers narrowly on radiopharmaceutical supply. The company manufactures, tests, and distributes diagnostic agents including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 fluorodeoxyglucose (FDG), and gallium-67, along with exclusive-rights therapeutics including Xofigo (radium-223 dichloride) for prostate cancer treatment and Lymphoseek for lymph node imaging. The company holds exclusive U.S. manufacturing and distribution rights for Lymphoseek and serves as the sole authorized federal supplier of Xofigo. Representative recent contracts include a $3.6 million indefinite-delivery contract with Veterans Integrated Service Network 4 (August 2026) for radiopharmaceuticals to the Pittsburgh Healthcare System, a $5.5 million indefinite-delivery contract with the Defense Health Agency (October 2025) for various radiopharmaceuticals, and a $6.9 million indefinite-delivery contract with the Defense Health Agency (April 2025) for radiopharmaceutical supply to Naval Medical Center Portsmouth. Recent delivery orders reflect smaller individual values—typically $100,000 to $500,000 per order—executed against these larger parent vehicles to support specific VA medical centers or military treatment facilities.
Customer concentration is heavily weighted toward the VA system. Veterans Integrated Service Network 8 accounts for $356.6 million across 166 awards (about 29% of total potential value), Veterans Integrated Service Network 22 accounts for $126.7 million across 176 awards, and the Defense Health Agency accounts for $76 million across 110 awards. Together, these three customers represent approximately 55% of Cardinal Health 414's combined potential value. The vendor maintains active single-award IDV contracts with 18 distinct VISNs and the Defense Health Agency, with individual contract ceilings ranging from roughly $88,000 to $6.95 million and performance periods extending through 2030 and 2031. No subcontracting footprint is present—Cardinal Health 414 competes and performs exclusively as a prime contractor.
Activity remained relatively flat over the past five years (ranging from 96 to 103 awards annually in 2022–2025), with 42 awards recorded in the first ten months of 2026. Total awards stand at 4,759 across the vendor's portfolio with combined potential value of $1.24 billion and obligated dollars of $389.8 million. A recompete cliff of $20.5 million in potential value falls within the next twenty-four months as existing IDVs reach ultimate completion and require renewal or rebid.
Cardinal Health 414's federal business model rests on regulatory barriers and proprietary product exclusivity. The company holds Nuclear Regulatory Commission licensing and FDA approvals for radiopharmaceutical manufacturing, Department of Transportation compliance for radioactive materials transport, and exclusive manufacturing and distribution rights for certain products that justify sole-source procurements. Nearly all awards carry the baseline description "radiopharmaceuticals" or site-specific variants; scope is highly specialized and time-sensitive, with delivery requirements as stringent as one-to-one-and-a-half-hour turnaround to accommodate short radioactive half-lives. The vendor operates as a critical infrastructure supplier with no competition on proprietary products and limited competitive exposure on standard diagnostic isotopes where regulatory licensing and established supply relationships create high barriers to entry.
Quick answers
Is Cardinal Health 414, LLC registered in SAM.gov?
Yes. Cardinal Health 414, LLC's SAM.gov registration is active through October 14, 2027.
How much has Cardinal Health 414, LLC received in federal contracts?
Federal contracts obligated $30,362,934 to Cardinal Health 414, LLC in fiscal year 2025 and $105,891,316 in fiscal years 2023 through 2027.
How does Cardinal Health 414, LLC rank among federal contractors?
Cardinal Health 414, LLC's parent company, Cardinal Health, Inc., ranked #4 in NAICS 325411, #11 in PSC 3650 and #15 in NAICS 325412 in FY2025.
What is Cardinal Health 414, LLC's most recent federal award?
Cardinal Health 414, LLC's most recent federal contract award is Radioisotopes fargo (36C26327N0126), from Veterans Integrated Service Network 23 (VHA), on October 1, 2026.
On GovTribe
See Cardinal Health 414, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors